Literature DB >> 20460187

Molecular mechanisms of pathogenesis of Parkinson's disease.

M I Shadrina1, P A Slominsky, S A Limborska.   

Abstract

Parkinson's disease is a complex disease characterized by a progressive degeneration of nigrostriatal dopaminergic neurons. The development of this condition is defined by the interaction between the genetic constitution of an organism and environmental factors. Analysis of the genes associated with development of monogenic forms of disease has allowed pointing out several mechanisms involved in Parkinson's disease pathogenesis such as the ubiquitin-proteasome degradation, differentiation of dopaminergic neurons, mitochondrial dysfunction, oxidative damage, and others. In this review, a variety of data which throw light on molecular mechanisms underlying pathogenesis of Parkinson's disease will be considered. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20460187     DOI: 10.1016/S1937-6448(10)81006-8

Source DB:  PubMed          Journal:  Int Rev Cell Mol Biol        ISSN: 1937-6448            Impact factor:   6.813


  20 in total

1.  Paraoxonase 2 (PON2) in the mouse central nervous system: a neuroprotective role?

Authors:  Gennaro Giordano; Toby B Cole; Clement E Furlong; Lucio G Costa
Journal:  Toxicol Appl Pharmacol       Date:  2011-02-23       Impact factor: 4.219

2.  Testosterone replacement attenuates haloperidol-induced catalepsy in male rats.

Authors:  Naime Majidi Zolbanin; Elmira Zolali; Alireza Mohajjel Nayebi
Journal:  Adv Pharm Bull       Date:  2014-02-07

3.  Metabolic Alterations and the Protective Effect of Punicalagin Against Glutamate-Induced Oxidative Toxicity in HT22 Cells.

Authors:  Kavitha Pathakoti; Lavanya Goodla; Manjunath Manubolu; Tewin Tencomnao
Journal:  Neurotox Res       Date:  2017-01-09       Impact factor: 3.911

4.  Inhibition of polyisoprenylated methylated protein methyl esterase by synthetic musks induces cell degeneration.

Authors:  Lambert Ayuk-Takem; Felix Amissah; Byron J Aguilar; Nazarius S Lamango
Journal:  Environ Toxicol       Date:  2012-04-04       Impact factor: 4.119

5.  Dopaminochrome induces caspase-independent apoptosis in the mesencephalic cell line, MN9D.

Authors:  Andrew J Linsenbardt; Julie M Breckenridge; Gerald H Wilken; Heather Macarthur
Journal:  J Neurochem       Date:  2012-05-09       Impact factor: 5.372

Review 6.  Manganese superoxide dismutase: guardian of the powerhouse.

Authors:  Aaron K Holley; Vasudevan Bakthavatchalu; Joyce M Velez-Roman; Daret K St Clair
Journal:  Int J Mol Sci       Date:  2011-10-21       Impact factor: 5.923

7.  Peripheral vs. Central Sex Steroid Hormones in Experimental Parkinson's Disease.

Authors:  Simon McArthur; Glenda E Gillies
Journal:  Front Endocrinol (Lausanne)       Date:  2011-11-30       Impact factor: 5.555

8.  NMDA receptor genotypes associated with the vulnerability to develop dyskinesia.

Authors:  S A Ivanova; A J M Loonen; P Pechlivanoglou; M B Freidin; A F Y Al Hadithy; E V Rudikov; I A Zhukova; N V Govorin; V A Sorokina; O Y Fedorenko; V M Alifirova; A V Semke; J R B J Brouwers; B Wilffert
Journal:  Transl Psychiatry       Date:  2012-01-10       Impact factor: 6.222

9.  Involvement of endocytosis and alternative splicing in the formation of the pathological process in the early stages of Parkinson's disease.

Authors:  Anelya Kh Alieva; Maria I Shadrina; Elena V Filatova; Aleksey V Karabanov; Sergey N Illarioshkin; Svetlana A Limborska; Petr A Slominsky
Journal:  Biomed Res Int       Date:  2014-04-03       Impact factor: 3.411

10.  8-OH-DPAT (5-HT1A agonist) Attenuates 6-Hydroxy- dopamine-induced catalepsy and Modulates Inflammatory Cytokines in Rats.

Authors:  Hamdolah Sharifi; Alireza Mohajjel Nayebi; Safar Farajnia
Journal:  Iran J Basic Med Sci       Date:  2013-12       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.